Abstract. Carbon isotopic compositions of suspended organic matter and biomarker compounds were determined for 59 samples filtered from Southern Ocean surface waters in January 1994 along two north-south transects (WOCE SR3 from Tasmania to Antarctica, and across the Princess Elizabeth Trough (PET) east of Prydz Bay, Antarctica). Along the SR3 line, bulk organic matter show generally decreasing 13C contents southward, which are well correlated with increasing dissolved molecular carbon dioxide concentrations, CO2(aq). This relationship does not hold along the PET transect. Using concentrations and isotopic compositions of molecular compounds, we evaluate the relative roles of several factors affecting the •513C of Southern Ocean suspended particulate organic matter. Along the WOCE SR3 transect, the concentration of CO2(aq) plays an important role. It is well described by a supply versus demand model for the extent of cellular CO2 utilization and its associated linear dependence of isotopic fractionation (ep) on the reciprocal of CO2(aq). An equally important factor appears to be changes in algal assemblages along the SR3 transect, with their contribution to isotopic fractionation also well described by the supply and demand model, when formulated to include the cell surface/volume control of supply. Changes in microalgal growth rates appear to have a minor effect on ep. Along the PET transect, algal assemblage changes and possibly changes in microalgal growth rates appear to strongly affect the carbon isotopic variations of suspended organic matter. These results can be used to improve the formulation of modem carbon cycle models that include phytoplankton carbon isotopic fractionation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.